A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Arterial Hypertension

Clinical trial NCT05147805 · COMPLETED

Trial details

NCT number: NCT05147805
Sponsor: Insmed Incorporated
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pulmonary Arterial Hypertension

Start date: 2022-08-24
Primary completion: 2025-03-27
Enrollment: 102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.